Medication for the maintenance treatment of bipolar disorder

shutterstock_162124046

Elena Marcus summarises a recent network meta-analysis published in The Lancet of the comparative efficacy and tolerability of medication for the maintenance treatment of bipolar disorder.

[read the full story...]

Understanding Psychosis and Schizophrenia: a critique by Laws, Langford and Huda

Screen Shot 2014-11-25 at 17.36.49

Keith Laws, Alex Langford and Samei Huda provide a critique of the British Psychological Society Division of Clinical Psychology report published today.

[read the full story...]

Efficacy of high vs. low-potency first-generation antipsychotics for schizophrenia

Screen Shot 2014-10-03 at 13.24.52

Laurence Palfreyman summarises 3 recent Cochrane reviews, which investigate high-potency versus low-potency first-generation antipsychotic drugs for schizophrenia. The reviews find little difference in efficacy between the high-potency antipsychotics Trifluoperazine, Haloperidol, Fluphenazine, and low-potency typical antipsychotics.

[read the full story...]

Second National Audit of Schizophrenia highlights lack of progress for service users and carers

shutterstock_164147468

André Tomlin summarises the second National Audit of Schizophrenia, which highlights that many people with schizophrenia are still not getting the high quality psychological and medical treatment they deserve.

[read the full story...]

Eating disorders: mapping the (lack of) evidence

shutterstock_80397523

Helen Bould summarises a recent review that maps the evidence for the prevention and treatment of eating disorders in young people. Her conclusion? A call to arms for more better quality research to help people affected by these serious illnesses.

[read the full story...]

The adverse effects of psychiatric drugs and emergency department visits

shutterstock_126460121

A new study finds that psychiatric medications are implicated in many adverse drug events treated in US emergency departments. Nearly 1 in 10 of all adverse drug event visits to emergency departments are due to psychiatric drugs, including antidepressants, antipsychotics, lithium salts, sedatives, anxiolytics and stimulants.

[read the full story...]

Shared decision making in antipsychotic prescribing: the perspective of psychiatrists

shutterstock_190044902

Shared decision making is now commonplace, but will this approach ever be fully embraced in relation to antipsychotic prescribing? Liz Hughes reports on a recent qualitative study of consultant psychiatrists’ experiences that sheds some light on the issue.

[read the full story...]

What should we prescribe for neuropsychiatric symptoms in Alzheimer’s disease?

shutterstock_70709260

Psychiatrist Andrés Fonseca considers how his clinical practice should change, after reading a systematic review and meta-analysis of drug treatment for neuropsychiatric symptoms in Alzheimer’s disease

[read the full story...]

Antipsychotics and mood stabilisers may reduce violent crime

shutterstock_150668030

John Baker reports on the first population based report of the positive effects of antipsychotic medication and mood stabilisers on reducing the risk of a conviction for violent crime, published in the Lancet in May.

[read the full story...]

Paliperidone Palmitate is no better than Haloperidol Decanoate at preventing relapse or controlling psychotic symptoms

shutterstock_150559310

Alex Langford summarises a relatively large and pragmatic study, which provides firm evidence that the newer antipsychotic, Paliperidone, is no better at preventing relapse or controlling psychotic symptoms than its decades-old comparator, Haloperidol.

[read the full story...]